Evidence map›Paper›PMID 39243352›Full record

ArticleProbiotics and antimicrobial proteins2025

Plant Defensin PgD1 a Biotechnological Alternative Against Plant Pathogens.

Alaide Cristina de Bem Matos, Elisa Maria Rodriguez Pazinatto Telli, Luana Coldebella Camillo, Gustavo Felippe da Silva, Mayra Juline Gonçalves, Ricardo Casa, Leo Rufato, Maria de Lourdes Borba Magalhães

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alaide Cristina de Bem MatosPrograma Multicêntrico de Pós-Graduação Em Bioquímica E Biologia Molecular, Universidade do Estado de Santa Catarina - UDESC, Lages, Santa Catarina, Brasil.
Elisa Maria Rodriguez Pazinatto TelliBiomedicina Universidade Do Planalto Catarinense, Lages, Santa Catarina, Brasil.
Luana Coldebella CamilloPrograma Multicêntrico de Pós-Graduação Em Bioquímica E Biologia Molecular, Universidade do Estado de Santa Catarina - UDESC, Lages, Santa Catarina, Brasil.
Gustavo Felippe da SilvaPrograma Multicêntrico de Pós-Graduação Em Bioquímica E Biologia Molecular, Universidade do Estado de Santa Catarina - UDESC, Lages, Santa Catarina, Brasil.
Mayra Juline GonçalvesDepartamento de P&D, Plant Colab Pesquisa E Desenvolvimento Ltda, Lages, Brazil.
Ricardo CasaDepartamento de Agronomia, Universidade do Estado de Santa Catarina - UDESC, Lages, Santa Catarina, Brasil.
Leo RufatoDepartamento de Agronomia, Universidade do Estado de Santa Catarina - UDESC, Lages, Santa Catarina, Brasil.
Maria de Lourdes Borba MagalhãesPrograma Multicêntrico de Pós-Graduação Em Bioquímica E Biologia Molecular, Universidade do Estado de Santa Catarina - UDESC, Lages, Santa Catarina, Brasil. maria.magalhaes@udesc.br.

Funding

Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina PAP2023011000003 FAPESC No 48/2022
6 · The paper itself

Abstract

Plant defensins are small antimicrobial proteins (AMP) that participate in the immune defense of plants through their antibacterial, antiviral and antifungal activities. PgD1 is a defensin from Picea glauca (Canadian Pine) and has antifungal activity against plant pathogens. This activity positions it as an alternative biotechnological agent to pesticides commonly used against these plant fungi diseases. The present study aimed to recombinantly produce PgD1 in Escherichia coli to characterize its in vitro antifungal potential against different phytopathogens. To achieve this, the coding gene was amplified and cloned into pET30a( +). Recombinant plasmid was subsequently introduced into E. coli for the soluble expression of defensin PgD1. To evaluate the antifungal activity of the expressed protein, the growth inhibition test was used in solid and liquid media for approximately 7 days against significant plant pathogens, that cause significant crop damage including: Botrytis cinerea, Colletotrichum gloeosporioides, Colletotrichum musae, Colletotrichum graminicola and Fusarium oxysporum. Additionally, stability assessments included temperature variation experiments and inhibition tests using dithiothreitol (DTT). The results showed that there was significant inhibition of the fungal species tested when in the presence of PgD1. Furthermore, defensin proved to be resistant to temperature variations and demonstrated that part of its stability is due to its primary structure rich in cysteine ​​residues through the denaturation test with dithiothreitol (DTT) where the antifungal activity of PgD1 defensin was inhibited. These data indicate that recombinant PgD1 could be utilized as a plant protection technology in agriculture.

Indexed as

Antifungal AgentsDefensinsPlant DiseasesPlant ProteinsBotrytisColletotrichumEscherichia coliFusariumRecombinant ProteinsAntifungal AgentsDefensinsPlant ProteinsRecombinant ProteinsAntifungal activityAntimicrobial proteinsCysteine-rich proteinsPicea glauca

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.